ReGenTree Reports Eye Drops Promote Corneal Healing in Phase 3 Trial
News
ReGenTree’s eye drop therapy RGN-259 was found to promote corneal healing in people with neurotrophic keratopathy (NK), results from a Phase 3 clinical trial show. The therapy also had durable ... Read more